Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.

Pancreas - 1 Jan 2017

Arnoletti Juan Pablo, Zhu Xiang, Almodovar Alvin J O, Veldhuis Paula P, Sause Ryan, Griffith Elizabeth, Corpus George, Chang Jeffrey C C, Fanaian Naʼim, Litherland Sally A

Abstract excerpt

OBJECTIVES: Aggressive spread and liver metastases are predominant features of pancreatic ductal adenocarcinoma (PDAC). This study investigates activation of PDAC circulating tumor cells (CTC) and immunosuppression in the portal venous system. METHODS: Portal venous and peripheral blood were collected during pancreaticoduodenectomy from patients with PDAC (n = 21) or other non-PDAC pancreatic conditions (n = 20)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Gene Expression Regulation, Neoplastic

Share to Neoplastic Cells, Circulating

Share to Pancreatic Neoplasms

Share to Portal Vein

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 27400259
DOI: 10.1097/MPA.0000000000000667

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.PMID 27400259Read ↗

Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

Comparative Immune profiling in Pancreatic Ductal Adenocarcinoma Progression Among South African patientsSemantic proximity Read ↗

Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.Semantic proximity Read ↗

KRAS mutations in pancreatic circulating tumor cells: a pilot study.Semantic proximity Read ↗

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).Semantic proximity Read ↗

Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic BiomarkersSemantic proximity Read ↗

Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic CancerSemantic proximity Read ↗

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS MutationsSemantic proximity Read ↗

Myeloid-derived suppressor cells and their role in pancreatic cancer.Semantic proximity Read ↗

Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.Semantic proximity Read ↗

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients.Semantic proximity Read ↗

Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.